- 全部删除
您的购物车当前为空
Taurohyodeoxycholic acid(牛磺酸去氧胆酸)是一种胆汁酸,在调节肝脏炎症微环境方面发挥着关键作用。THDCA可以减少TNF-α和IL-6的表达并抑制肝细胞癌(HCC)的发展。能够结合黄芪多糖抑制非酒精性脂肪性肝病,调节胆汁酸代谢:通过上调CYP7B1和下调CYP7A1,降低肝脏中CD36的表达,减少肝脏脂质积累。

Taurohyodeoxycholic acid(牛磺酸去氧胆酸)是一种胆汁酸,在调节肝脏炎症微环境方面发挥着关键作用。THDCA可以减少TNF-α和IL-6的表达并抑制肝细胞癌(HCC)的发展。能够结合黄芪多糖抑制非酒精性脂肪性肝病,调节胆汁酸代谢:通过上调CYP7B1和下调CYP7A1,降低肝脏中CD36的表达,减少肝脏脂质积累。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 373 | In stock | |
| 5 mg | ¥ 893 | In stock | |
| 10 mg | ¥ 1,290 | In stock | |
| 25 mg | ¥ 2,330 | In stock | |
| 50 mg | ¥ 3,490 | In stock | |
| 100 mg | ¥ 4,970 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,030 | In stock |
Taurohyodeoxycholic acid 相关产品
| 产品描述 | Taurohyodeoxycholic acid (THDCA) is a bile acid that plays a key role in regulating the hepatic inflammatory microenvironment.THDCA reduces the expression of TNF-α and IL-6 and inhibits the development of hepatocellular carcinoma (HCC). It is able to inhibit non-alcoholic fatty liver disease and regulate bile acid metabolism in combination with astragalus polysaccharides: it reduces CD36 expression in the liver and decreases hepatic lipid accumulation by up-regulating CYP7B1 and down-regulating CYP7A1. |
| 别名 | 牛磺猪去氧胆酸, Taurohyodeoxycholic Acid MaxSpec® Standard |
| 分子量 | 499.7 |
| 分子式 | C26H45NO6S |
| CAS No. | 2958-04-5 |
| Smiles | C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)[C@@]([C@@H](CCC(NCCS(=O)(=O)O)=O)C)(CC4)[H])[H])(C[C@H](O)[C@@]1(C[C@H](O)CC2)[H])[H])[H] |
| 密度 | 1.216 g/cm3 (Predicted) |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容